E. Lattuada, F. Cocchi, M. Rossattini, A. Soldarini, G. Gentilini, F. Dorigatti, R. Cavallaro - Vol. 10, June 2004, Issue 2
Testo Immagini Bibliografia Summary Indice
Clozapina "brand" e clozapina
generica nel trattamento della schizofrenia farmacoresistente: bioequivalenza
ed intercambiabilità
Brand-name versus generic clozapine for the treatment of resistant
schizophrenia: bioequivalence and interchangeability issues
1 Kane JM. Pharmacologic treatment of schizophrenia. Biol Psychiatry 1999;46:1396-408.
2 Buchanan RW. Clozapine: efficacy and safety. Schizophr Bull 1995;21:579-91.
3 Cavallaro R, Brambilla P, Smeraldi E. The sequential treatment approach to resistant schizophrenia with risperidone and clozapine: results of an open study with follow-up. Human Psychopharmacology 1998;13:91-7.
4 Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 2001;58:518-26.
5 Simpson GM. The treatment of tardive dyskinesia and tardive dystonia. J Clin Psychiatry 2000;61:39-44.
6 Van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull 1999;25:741-8.
7 Barbini B, Scherillo P, Benedetti F, Crespi G, Colombo C, Smeraldi E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol 1997;12:109-12.
8 Kusumakar V. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder. J Clin Psychiatry 2002;63:23-8.
9 Mansour HA, Alda M, Nimgaonkar VL. Pharmacogenetics of bipolar disorder. Curr Psychiatry Rep 2002;4:117-23.
10 Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998;59:103-7.
11 Parker GF. Clozapine and borderline personality disorder. Psychiatr Serv 2002;53:348-9.
12 Brandstadter D, Oertel WH. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 2002;58:156-62.
13 Meyer MC. United States Food and Drug Administration requirements for approval of generic drug products. J Clin Psychiatry 2001;62:4-9.
14 Tse G, Thompson D, Procyshyn RM. Generic clozapine: a cost-saving alternative to brand name clozapine? Pharmacoeconomics 2003.
15 Sajbel TA, Carter GW, Wiley RB. Converting patients from brand-name clozapine to generic clozapine. Ann Pharmacother 2001;35:281-4.
16 Makela EH, Cutlip WD, Stevenson JM, Weimer JM, Abdallah ES, Akhtar RS, et al. Branded versus Generic Clozapine for Treatment of Schizophrenia. Ann Pharmacother 2003;37:350-3.
17 Stoner SC, Lea JW, Dubisar B, Marken PA, Ramlatchman LV, Reynolds J. A program to convert patients from trade-name to generic clozapine. Pharmacotherapy 2003;23:806-10.
18 Mofsen R, Balter J. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Clin Ther 2001;23:1720-31.
19 Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J Clin Psychiatry 2001;62:14-7.
20 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington DC: APA 1994.
21 Conley RR. Optimizing treatment with clozapine. J Clin Psychiatry 1998;59:44-8.
22 Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
23 Volpicelli SA, Centorrino F, Puopolo PR, Kando J, Frankenburg FR, Baldessarini RJ, et al. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clin Chem 1993;39:1656-9.
24 Haring C, Meise U, Humpel C, Saria A, Fleischhacker WW, Hinterhuber H. Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age. Psychopharmacology 1989;99:38-40.
25 Lane HY, Chang YC, Chang WH, Lin SK, Tseng YT, Jann MW. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J Clin Psychiatry 1999;60:36-40.
26 Otto A. Clozapine: Controversy Erupts over brand/generic equivalence. Pharmacy Today 2000;6:22-3.
27 Bender KJ. FDA confronts possible generic inequivalence. Psychiatric Times 2001;18:16-7.
28 Ereshefsky L, Lam YWF, Toney GB, et al. Clozapine bioequivalence in patients. New Research 710. 153rd Annual Meeting of the American Psychiatric Association, Chicago 2000.
29 Toney GB, Ereshefsky L, Lam YWF, et al. Interchangeability of clozapine formulation in stabilized patients. New Research 711. 153rd Annual Meeting of the American Psychiatric Association, Chicago 2000.
30 Ereshefsky L, Glazer WM. Comparison of the bioequivalence of generic versus branded clozapine. J Clin Psychiatry 2001;62:25-7.